NYSE$AHR

American Healthcare REIT Inc · Q3 2025 earnings

Q3 2025 earnings · · After market close · Investor relations

Briefing

American Healthcare REIT reported Q3 2025, revenue of $180M, net income of $25M, diluted EPS of $0.12.

For Q3 2025, American Healthcare REIT reported revenue of $180M, net income of $25M, diluted EPS was $0.12. Management discusses operations, liquidity, and outlook in the quarterly filing.

  • Revenue $180M.
  • Net income $25M.
  • Diluted EPS $0.12.

Headline financials

Total Revenue

$573M

Previous: $477M+20.2%
EPS (adj)

$0.12

Previous: -$0.03+500.0%
Capital Expenditures

-$340M

Previous: -$52.1M-553.3%
Free Cash Flow

-$284M

Previous: -$56.2M-405.9%
Net Income

$55.9M

Previous: -$4.13M+1455.5%
Operating Income

$106M

Previous: $93.5M+13.1%
Gross Profit

$118M

Previous: $59.7M+98.3%

Revenue & EPS history

American Healthcare REIT Inc · Revenue · Quarterly

$573M

Q3 2025+20.2%vs Q3 2024
Beat estimate in 3 of 8 quarters(38%)
ActualEstimate

Revenue by segment

American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024

  • ISHC
    $423M—
  • SHOP
    $73.5M—
  • Outpatient Medical
    $33.3M—
  • Triple-Net Leased
    $12.6M—

Forward guidance

The filing discusses American Healthcare REIT's outlook, including capital allocation, operating priorities, and market risks relevant to the reported quarter.

Tailwinds

  • American Healthcare REIT cites operational priorities and demand trends supporting the outlook.
  • Balance sheet and liquidity actions aim to fund growth and returns.

Headwinds

  • Macro, pricing, and input-cost volatility could pressure margins.
  • Segment mix and one-time items may affect quarter-to-quarter comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 11 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

+1.8%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.9%

Avg return

30 days after

64%

7 / 11 earnings

Positive

+8.3%

Q1 2025

Best reaction

-2.1%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026———
Q1 2026+4.3%+4.1%-4.2%
Q4 2025-2.1%-2.5%-11.4%
Q3 2025+3.0%-0.1%+4.6%
Q2 2025+1.3%+2.0%+7.2%
Q1 2025+8.3%+6.1%+10.2%
Q4 2024-1.3%+0.7%+0.8%
Q3 2024+1.2%+2.7%+7.1%
Q2 2024+3.3%+3.6%+35.1%
Q1 2024-0.1%+3.5%+6.2%
Q2 2023+2.8%+1.3%-6.8%
Q4 2023-0.8%+3.2%-5.9%
Q3 2023———
Q1 2023———
Q4 2022———
Q3 2022———
Q2 2022———
Q1 2022———
Q4 2021———
Q3 2021———
Q2 2021———
Q1 2021———
Q4 2020———
Q3 2020———
Q2 2020———
Q1 2020———
Q4 2019———
Q3 2019———
Q2 2019———
Q1 2019———
Q3 2018———
Q2 2018———
Q1 2018———
Q3 2017———
Q2 2017———
Q1 2017———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro